• By ICR Secretariat
  • Posted Thursday, May 19, 2022

FDA rejects two China-developed cancer drugs

https://www.biopharmadive.com/news/fda-reject-hutchmed-junshi-china-developed-cancer-drug/623024/

The Food and Drug Administration has refused to approve two cancer treatments developed by Chinese drugmakers, citing trial design in one rejection and manufacturing issues in the other.